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S u m m a r y  
 
O b j e c t i v e s .  Leg ischemia is the third leading cause 
of atherosclerotic cardiovascular morbidity, concerning about 
20-30% of the elderly population. Recognition of its risk 
factors helps in early diagnosis and patient management.  The 
aim of this study was to determine the prevalence of 
respective atherosclerosis risk factors among patients with 
peripheral artery disease (PAD) referred for lower limb 
endovascular revascularization and compare their prevalence 
with the data obtained in large epidemiological investigations 
and in patients with atherosclerosis manifestation in coronary 
and cerebral vascular beds.  
M a t e r i a l  a n d  m e t h o d s .  Medical 
documentation for 73 male patients with PAD after a first 
endovascular intervention was evaluated retrospectively, and 
the prevalence of atherosclerosis risk factors found was 
compared with historical control groups from the literature.  
R e s u l t s .  The patients studied presented significantly 
greater prevalence of a current smoking habit and diabetes 
mellitus than in the POLSCREEN, WOBASZ and NATPOL 
PLUS studies, significantly greater prevalence of 
hypertension than in WOBASZ and NATPOL PLUS, 
significantly greater prevalence of dyslipidemia than in 
POLSCREEN and NATPOL PLUS, significantly lower 
prevalence of BMI ≥ 25 kg/m2 than in POLSCREEN, and 
greater than in NATPOL PLUS. In comparison to patients 
with coronary artery disease (CAD), individuals with PAD 
had a lower prevalence of hypertension and overweight 
and/or obesity, but greater occurrence of a current smoking 
habit and dyslipidemia. 
C o n c l u s i o n s .  Patients with PAD who were 
qualified for endovascular therapy presented greater 
prevalence of atherosclerosis risk factors and multisite 
vascular disease manifestation than various general Polish 
populations and subjects with CAD, which suggests the need 
for the improved management of these patients.    
 
 
S t r e s z c z e n i e  
 
C e l e .  Przewlekłe niedokrwienie kończyn dolnych 
(PNKD) jest trzecim, co do częstości, schorzeniem sercowo- 
naczyniowym, dotyczącym około 20-30% dorosłej populacji. 
Określenie czynników ryzyka PNKD jest istotne dla 
wczesnej diagnozy i właściwego leczenia chorych. Celem 
pracy było porównanie częstości występowania 
poszczególnych czynników ryzyka u pacjentów leczonych 
wewnątrznaczyniowo z powodu PNKD z danymi 
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pochodzącymi z dużych badań epidemiologicznych w Polsce 
dotyczących populacji ogólnej, pacjentów z chorobą naczyń 
wieńcowych i mózgowych.  
M a t e r i a ł  i  m e t o d y .  Dokonano retrospektywnej 
oceny dokumentacji medycznej 73 mężczyzn leczonych po 
raz pierwszy wewnątrznaczyniowo z powodu PNKD, a 
stwierdzoną częstość występowania głównych czynników 
ryzyka miażdżycy porównano z danymi z piśmiennictwa.  
W y n i k i .  Badani pacjenci z PNKD znamiennie 
częściej palili tytoń i mieli cukrzycę w porównaniu z wyniki 
polskich badań epidemiologicznych, takich jak: 
POLSCREEN, WOBASZ i NATPOL PLUS. Prezentowali 
oni znamiennie częstsze występowania nadciśnienia 
tętniczego niż w badaniach WOBASZ i NATPOL PLUS, 
większą częstość dyslipidemii niż w badaniach 
POLSCREEN i NATPOL PLUS oraz większą częstość BMI 
≥ 25 kg/m2 niż w badaniu POLSCREEN i mniejszą niż w 
badaniu NATPOL PLUS. W porównaniu z pacjentami z 
chorobą wieńcową (CHW) pacjenci z PNKD mieli 
znamiennie rzadziej nadciśnienie tętnicze, nadwagę lub 
otyłość, ale częściej palili i mieli dyslipidemię.  
W n i o s k i . Pacjenci z PNKD prezentowali większą 
częstość i nasilenie czynników ryzyka miażdżycy oraz 
wielopoziomowej manifestacji miażdżycy niż osoby z 
populacji ogólnej oraz pacjenci z CHW, co wskazuje na 
konieczność poprawy leczenia zachowawczego w tej grupie 
chorych.  
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Lower extremity peripheral artery disease (PAD) is 
the third leading cause of atherosclerotic 
cardiovascular morbidity, following coronary artery 
disease (CAD) and stroke. However, among patients 
with only one location of significant atherosclerotic 
lesions, cardiovascular mortality is significantly higher 
with PAD (11.3%) than with cerebrovascular disease 
(6%) or CAD (5.1%) [1]. PAD has become a global 
problem due to the increase in life expectancy and 
morbidity in the 21st century [2]. Among those aged 
75, the total percentage of PAD patients amounts to 
30%, of whom, however,  only 30% again are 
symptomatic [3-5]. In a recent meta-analysis of 34 
investigations based on 112,027 participants, the PAD 
prevalence in men in high-income countries was 5.41% 
(3.41-8.49%) at age 45-49 and 18.83% (12.03-28.25%) 
at age 85-89 [2]. Atherosclerotic cardiovascular 
diseases develop in response to a combination of 
several risk factors, such as age/gender, smoking 
habits, dyslipidemia, hypertension, diabetes, mellitus, 
overweight/obesity, and low physical activity [5,6]. It 
is generally known that the presence of more risk 
factors in one person increases his or her risk of the 
occurrence of a cardiovascular event or death. For this 
reason, interactive risk calculators, e.g. SCORE or 
HeartScore, are proposed to improve the prediction of 
cardiovascular events after 10 years in asymptomatic 
persons aged mainly 40-65. The main purpose for 
using these calculators is to avoid both under- and 
overtreatment [6]. However, such multifactorial risk 
assessment is more effective at predicting heart attacks 
than strokes, and has significantly less usefulness in 
predicting the need for lower extremity 
revascularization. This suggests that the risk factors for 
PAD may be different to those for CAD or that there 
are differences in the extent of the influence of 
respective risk factors on atherosclerosis manifestation 
in various vascular beds [7, 8]. It is also possible that, 
due to differences in the histology of the aorta, iliac 
and femoral arteries, the respective atherosclerosis risk 
factors among patients with PAD show different 
effects on the severity of the lesions in respective 
vascular territories [7]. Less knowledge concerning the 
risk factors for PAD than those for CAD may be one of 
the significant reasons for primary amputation still 
being the method of choice in the treatment of critical 
limb ischemia in 5-20% of patients, with a 4-30% risk 
of periprocedural death and a 30-45% risk of 12-month 
mortality [4, 5].   
There are known to be several types of 
atherosclerosis manifestation, such as myocardial 
infarction, ischemic stroke, or peripheral, including 
visceral, artery disease. They may overlap 
(polyvascular disease, multisite atherosclerosis), in 
which case the risk of cardiovascular event and 
mortality increases significantly [4, 5, 9-14]. 
Sometimes, the respective types of vascular disease 
prevalence demonstrate a family association, which 
suggests that they may be related to composite 
domestic factors; not only genetic, but also, for 
example, active and passive smoking habits, diet, 
overeating, low physical activity, stress, alcohol abuse, 
etc. These factors should be identified in patients with 
PAD and used in an educational process that not only 
concerns the patients, but also their families. In other 
words, the recognition of the predominant risk factors 
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in patients with respective type of atherosclerosis 
manifestation would not only improve our knowledge 
of vascular diseases, but may also help to individualize 
the prevention strategy for vascular disease. It is 
frequently difficult to obtain from elderly people with 
PAD information concerning the kind of 
atherosclerosis clinical presentation experienced by 
their parents, although it is usually too late to 
implement prevention measures in such a population. 
However, we can identify the younger family members 
of patients treated due to leg ischemia and recommend 
a preventive strategy to them with the emphasis on the 
most important factors, e.g. tobacco use. The value of 
such treatment would also result from the fact that we 
still not have guidelines on how to screen the 
population in regard to PAD risk and prevalence and, 
because of this, the number of PAD patients is 
underestimated and this group remains undertreated 
[15]. The premises discussed above represent the 
rationale behind our analysis, the aim of which was to 
determine the prevalence of respective atherosclerosis 
risk factors among patients referred for lower limb 
endovascular revascularization and compare their 
prevalence with the data obtained from large 
investigations on the general population and patients 
with various syndromes of atherosclerosis 




We retrospectively evaluated the medical 
documentation of 73 consecutive male patients with 
PAD treated endovascularly between 2008 and 2013 
with stenting due to lower extremity artery 
atherosclerosis. The inclusion criteria were as follows: 
a) first-time stenting of lower extremity arteries due to 
chronic leg ischemia in the course of atherosclerosis; 
b) blood creatinine concentration within normal range; 
c) complete follow-up for at least one year with visits 
at 1, 3, 6, and 12 months after the endovascular 
procedure, and further follow-up at least 6 months after 
that, twice in the year. The exclusion criteria were: a) 
stent occlusion due to thrombosis or fracture; b) lack of 
compliance with changes suggested by the medical 
team (e.g. to lifestyle or medication); and c) the need 
for surgical revascularization during the follow-up 
after stenting.  
The following parameters were analyzed: age, 
smoking habits, hypertension, dyslipidemia (defined as 
increased blood low-density lipoprotein [LDL] 
cholesterol concentration above 100 mg/dl, and/or 
triglyceride blood concentration above 150 mg/dl, or 
hypolypemic treatment on admission for a first 
endovascular procedure), diabetes mellitus, body mass 
index (BMI), and a history of CAD and stroke.  
 
MAIN OUTCOMES MEASURED 
 
The prevalence of respective atherosclerosis risk 
factors in comparison to the data from large 
epidemiological studies on Polish populations 
(POLSCREEN, 400 Towns Project, WOBASZ, 
NATPOL PLUS) [16], as well as a comparison of 
these risk factors to recent data concerning the 
frequency of atherosclerosis risk factors in patients 
with chronic coronary syndromes (POLSCREEN 
CAD) [16], acute coronary syndromes [17], both with 
sustained ST-segment elevation (STEMI) [18] and 
with non-sustained ST-segment elevation (NSTEMI) 
[19], in addition to acute cerebral manifestations of 
vascular disease (a large Polish study was not 




The study protocol was approved by the local 
Bioethics Committee (agreement number 
KB139/2014). All procedures were conducted in 




Statistical analysis was conducted using a licensed 
version of statistical software STATISTICA PL 10.0 
for Windows. The normal distribution of the study 
variables was checked using the Shapiro-Wilk test. The 
results were mainly presented as n, % and the mean  
standard deviation (SD). The statistical significance of 
differences between the patients in our own study and 
historical control groups (references data) was 




Seventy-three male patients were included in the 
analysis. They had qualified for endovascular treatment 
of lower limb ischemia due to life-activity-limiting 
claudication (n = 55, 75%) and critical limb ischemia 
(n = 18, 25%). In comparison to general but various 
Polish populations (historical control group) (Tab. I), 
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our patients presented: (a) significantly greater 
prevalence of a current smoking habit and diabetes 
mellitus than those in all the epidemiological 
investigations chosen for comparison, (b) significantly 
greater prevalence of hypertension than in the 
WOBASZ and NATPOL PLUS studies, (c) 
significantly greater prevalence of dyslipidemia than 
that found in the POLSCREEN and NATPOL PLUS 
studies, and (d) significantly greater prevalence than in 
the NATPOL PLUS study for both overweight and/or 
obesity (BMI ≥ 25 kg/m
2
) and obesity (BMI ≥ 30 
kg/m
2
) (Tab. I). 
In the next part of the analysis (Tab. II), we 
compared the prevalence of respective atherosclerosis 
risk factors in the analyzed patients with PAD with the 
literature data concerning individuals with various 
clinical manifestations of atherosclerosis in other 
vascular beds (chronic and acute coronary syndromes 
and ischemic stroke). Our patients with PAD, in 
comparison to patients with chronic CAD 
(POLSCREEN CAD), had a lower prevalence of 
hypertension and overweight and/or obesity, but a 
greater occurrence of a current smoking habit and 
dyslipidemia (Tab. II) [16]. In comparison to patients 
Table 1. Prevalence of atherosclerosis risk factors in male patients treated endovascularly due to lower limb ischemia and the 
prevalence of such conditions in selected epidemiological studies. On the base of data presented by Cieśliński et al. 
[16] 
Tabela 1. Częstość poszczególnych czynników ryzyka miażdżycy u pacjentów leczonych wewnątrznaczyniowo z powodu 
przewlekłego niedokrwienia kończyn dolnych oraz w wybranych polskich badaniach epidemiologicznych wg 





(n = 73) 
POLSCREEN  
(n = 246,313)  
400 Towns Project 
Projekt 400 miast 
(n = 1,708)  
WOBASZ 
(n = 6,392) 
NATPOL PLUS  
(n = 3,050)  
Age (years); range or mean ± SD 
Wiek (lata); przedział lub średnia ± SD 
62.8 ± 8.5 
≥ 35 years 
≥ 35 lat 
18-92 20-74 18-94 
Current smoking (n, %) 
Aktualne palenie (n, %) 
40 (55%) 29.3%+ 22.9%+ 49.4%* 40%+ 
Hypertension (n, %) 
Nadciśnienie (n, %) 
51 (70%) 71.2% 65.8% 42%+ 29%+ 
Diabetes (n, %) 
Cukrzyca (n, %) 
20 (27%) 16%* 7%+ 7% (16%a)+   5.6%+ 
Dyslipidemia (n, %) 
Dyslipidemia (n, %) 
57 (78%) 67.1%* 69.9% 74%  60%+ 
LDL ≥ 100 mg/dl (n, %) 50 (69%)   60% 60.1% 
Triglycerides  
≥ 150 mg/dl (n, %) 
Trójglicerydy  
≥ 150 mg/dl (n, %) 
19 (26%)    30.1% 
Fasting glucose  
≥ 100 mg/dl (n, %) 
Glukoza na czczo  
≥ 100 mg/dl (n, %) 
35 (48%)  39.7%   
BMI (kg/m2) 27.6 ± 5.0 27.9 ± 4.0    
BMI ≥ 25 kg/m2 (n, %) 49 (67%) 76.6%* 73.7% 61.6% 52.7%* 
BMI ≥ 30 kg/m2 (n, %) 21 (29%) 26.8% 27.3% 20.2% 19%* 
History of myocardial infarction (n, %) 
Przebyty zawał serca 
(n, %) 
32 (44%) 13%+    
Past stroke (n, %) 
Przebyty udar (n, %) 
8 (11%) 3%+    
History of PAD (n, %) 
Wywiad niedokrwienia kończyn 
73 (100%) 11%+    
 
Abbreviations: SD = standard deviation; a = patients 65-74 years of age; LDL = low-density lipoprotein; BMI = body mass 
index; PAD = peripheral artery disease; statistical significance of the difference between our results and those obtained in 
respective epidemiological investigations carried out by Chi2 test: * = p < 0.05; + = p < 0.001 
Skróty: SD = odchylenie standardowe; a = pacjenci w wieku 65-74 lat; LDL = cholesterol w lipoproteinach o niskiej gęstości; 
BMI = wskaźnik masy ciała; PAD = choroba naczyń obwodowych; znamienność statystyczna różnicy między wynikami 
własnymi oraz danymi z poszczególnych badań epidemiologicznych w teście Chi2: * = p < 0.05; + = p < 0,001 
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on the Polish Registry of Acute Coronary Syndromes 
(PL-ACS) [17], our subjects appeared to have had a 
more frequent occurrence of: a smoking habit, 
hypertension, dyslipidemia, obesity, and past 
myocardial infarction (Tab. II). Similar factors, with 
the exception of hypertension, were more prevalent in 
the patients in our study than in individuals with 
STEMI [18] and in octogenarians with NSTEMI [19]. 
Compared with the historical control, the patients in 
our study with PAD with acute ischemic stroke [20] 
presented significantly more frequently with a smoking 
habit, dyslipidemia and past myocardial infarction 




In our study we compared the prevalence of 
respective traditional atherosclerosis factors in male 
PAD patients referred for elective endovascular 
intervention with their reported frequency in various 
Table 2. Prevalence of atherosclerosis risk factors in male patients treated endovascularly due to lower limb ischemia and the 
prevalence of such conditions in selected studies on stable coronary artery disease, acute coronary syndromes and 
ischemic stroke. On the base of data presented in respective references [16-20] 
Tabela 2. Częstość poszczególnych czynników ryzyka miażdżycy u pacjentów leczonych wewnątrznaczyniowo z powodu 
przewlekłego niedokrwienia kończyn dolnych oraz w wybranych badaniach u pacjentów ze stabilną chorobą 





(n = 73 males) 
POLSCREEN 
CAD  




2012 (n = 
4,144, 
59% male) [17] 
STEMI < 65 yr 
(n = 280 males) 
[18] 
STEMI > 65 yr 
(n = 415 males) 
[18] 
NSTEMI > 80 yr 





(n = 571,  
65% male) 
[20] 
Age (years); range 
or mean ± SD 
Wiek (lata); 
przedział lub 
średnia ± SD 
62.8 ± 8.5 63 ± 10 68 ± 12 55 ± 6.0 74.6 ± 6.3 80-105 











51 (70%) 80%* 52%* 67.9% 77.1% 72.8% 69.2% 
Diabetes (n, %) 
Cukrzyca (n, %) 





57 (78%) 48%+ 32%+ 64.3%* 52.8%* 33.5%+ 64.5%* 
BMI ≥ 25 kg/m2 
(n, %) 
49 (67%) 79%*      
BMI ≥ 30 kg/m2 
(n, %) 
21 (29%) 29% 19%* 15%+ 11.8%+ 14.9%+  
History of 
myocardial 
infarction (n, %) 
Przebyty zawał 
serca (n, %) 
32 (44%)  26%+ 28.9* 37.1% 22.4%+ 15.8%+ 
Past stroke (n, %) 
Przebyty udar  
(n, %) 
8 (11%)      14.2% 
 
Abbreviations: PL-ACS registry = Polish Registry of Acute Coronary Syndromes; STEMI = ST segment elevation myocardial 
infarction; NSTEMI = non-ST segment elevation myocardial infarction; SD = standard deviation; BMI = body mass index; 
statistical significance of the difference between own results and those obtained in respective epidemiological investigations 
carried out by Chi2 test: * = p < 0.05; + = p < 0.001.  
Skróty: PL-ACS registry = Polski Rejestr Ostrych Zespołów Wieńcowych; STEMI = ostry zwał serca z przetrwałym 
uniesieniem odcinka ST; NSTEMI = ostry zawał serca bez przetrwałego uniesienia odcinka ST; SD = odchylenie 
standardowe; BMI =wskaźnik masy ciała; znamienność statystyczna różnicy między wynikami własnymi oraz danymi z 
poszczególnych badań epidemiologicznych w teście Chi2: * = p < 0.05; + = p < 0,001. 
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Polish epidemiological investigations on general large 
populations (Tab. I) and in groups of individuals with 
different sites and types of atherosclerosis 
manifestation, such as stable and unstable coronary 
artery disease, and with ischemic stroke (Tab. II).    
Our analysis showed that in comparison to general 
Polish populations our patients with advanced and 
symptomatic PAD were more frequently diabetics (on 
average 1.5-4.8 times), smokers (on average 1.3-2 
times), and dyslipidemic (on average 1.05-1.3 times), 
but they presented a lower (by 15%) prevalence of 
overweight and/or obesity (BMI ≥ 25 mg/kg
2
) than in 
the POLSCREEN study. The last observation may be 
seen as surprising but a lower odds ratio (OR) for 
being overweight and being obese in PAD subjects 
compared to those in the control group had previously 
been reported [7]. Our other observations also 
corroborate data obtained by other researchers. In a 
recent meta-analysis of 34 papers by Fowkes et al. [2], 
a smoking habit was an important risk factor for PAD 
in both high-income and low-middle-income countries, 
with meta-OR for current tobacco use of 2.72 (95% CI 
2.39-3.09) and 1.42 (1.25-1.62), respectively, followed 
by diabetes mellitus (1.88 [1.66-2.14] vs 1.47 [1.29-
1.68]), hypertension (1.55 [1.42-1.71] vs 1.36 [1.24-
1.50]), and hypercholesterolemia (1.19 [1.07-1.33] vs 
1.14 [1.03-1.25]). In a study by Poredoš et al. [8], 
cigarette smoking and diabetes mellitus also 
represented the greatest risks for PAD. In other work, 
age, duration of diabetes, smoking habits, high blood 
pressure and an HbA1c > 7% were significant 
predictors of PAD, while obesity did not correlate with 
PAD [21]. Whereas, in a study by Bez and Navarro 
[10], of the patients with PAD investigated, 86% had 
hypertension, 66% exposure to tobacco smoke, 47% 
diabetes, 65% dyslipidemia, 24% coronary artery 
disease, 16% renal failure, and 60% a family history of 
cardiovascular disease [10]. It seems worth underlining 
at this point that in trying to explain such a high 
incidence of hypertension in patients with PAD (70% 
in our study of patients with normal creatinine levels) 
in comparison with other populations, the potential 
coexistence of renal artery stenosis (RAS) should be 
taken into account [14] because, in an analysis by Endo 
et al. [22] of 410 Japanese patients with PAD, 22.9% 
had RAS > 50% and 11.0% had RAS > 75%.  
Although the above-cited papers report a 
comparable prevalence of respective cardiovascular 
risk factors, in a study by Sumner et al. [23] only 38% 
of a population with PAD had metabolic syndrome, 
which doubles the risk of having PAD. On the other 
hand, in Korean diabetic patients, the PAD prevalence 
was 3.2% [24]. Moreover, it is sometimes not possible 
to determine atherosclerosis risk factors in patients 
with PAD. Among 1,932 study participants without 
traditional atherosclerosis risk factors, a low (≤ 0.9) 
ankle-brachial index (ABI) was found in 176 (9%) 
cases and a high ABI (≥ 1.3) in 149 (7.8%) cases. Only 
a lower glomerular filtration rate and higher 
interleukin-6 level were associated with low ABI with 
statistical significance, and past smoking (cessation > 
10 years) and pulse pressure had a borderline 
association with low ABI [25].  
Our patients with PAD also presented a 
significantly greater prevalence of past cardiovascular 
events from other vascular territories than in the 
general Polish population investigated in the 
POLSCREEN study (Tab. I). It is obvious because of 
an atherosclerosis is an systemic disease, and its 
polyvascular (multisite) manifestation concern 15-60% 
of patients with PAD, and PAD presence is recognized 
as equivalent or at least risk factors for coronary or 
cerebrovascular diseases [5]. The similar prevalence of 
previous stroke in our patients with PAD and in 
individuals with acute ischemic stroke suggests g PAD 
recognition as an clinical equivalent of stroke (Tab. II), 
although such a suggestion would not change PAD 
patient management due to the same therapeutic targets 
in the secondary prevention of very high-risk 
individuals [5, 6].  
In our study we also tried to test the hypothesis that 
various traditional atherosclerosis risk factors, although 
the same for PAD, CAD, and cerebrovascular diseases, 
differ in the power of the association between them and 
vascular lesion severity in respective vascular 
territories [5, 6, 26]. For this purpose we compared the 
prevalence of respective risk factors in our PAD 
patients with their prevalence in patients with CAD 
and ischemic stroke (Tab. II). Our subjects with PAD 
were more frequently smokers and dyslipidemic than 
patients with CAD and stroke, but they presented less 
frequently a BMI above 25 kg/m
2
. The other studies 
also confirmed the predominant effect of smoking 
habits on PAD occurrence in comparison to the other 
vascular beds of atherosclerosis manifestation. In a 
study by Radak et al. [27] the most significant risk 
factors for PAD were smoking (97%), hyperlipidemia, 
and a family history of atherosclerotic disease. In work 
by Agarwal and Naderi [28], in comparison with CAD 
patients, subjects with PAD were more frequently 
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female, black, and active smokers. Moreover, in this 
study, patients with PAD had significantly higher 
serum concentrations of LDL cholesterol and C-
reactive protein than those with CAD alone [28]. In 
another study, among patients with chronic splanchnic 
ischemia, female predominance (74%) but a lower 
incidence of obesity/increased bodyweight (21%), 
diabetes mellitus (21%), hypertension (62%), and 
hypercholesterolemia (53%) than in patient groups 
with atherosclerosis of other vascular territories were 
observed [29]. 
In spite of some limitations, such as the 
retrospective type of the analysis and the small sample 
size, our results regarding male patients with PAD 
referred for elective endovascular intervention may 
have several practical implications. First, our results 
show that the achievement of target levels for 
controlling traditional atherosclerosis risk factors in the 
21
st
 century remains poor. However, elective 
interventions for lower extremity arteries give an 
opportunity to identify the atherosclerosis risk factors 
in respective PAD patients to start secondary 
prevention, as well as diagnosing the presence of 
concomitant atherosclerotic lesions in the remaining 
vascular territories, especially as the effectiveness of 
the routine management of risk factors in primary care 
in Poland is very low [30]. The most important target 
for PAD prevention seems to be stopping smoking, 
despite the results of a multivariate analysis by Alvarez 
et al. [31] that showed that after smoking cessation the 
relative risk of death for those who had quit smoking 
was 0.20 (95% CI 0.05-0.75) in patients with CAD, 0.0 
in those with cerebrovascular disease, and 1.83 (95% 
CI 0.65-5.15) in those with PAD, which suggests that 
tobacco withdrawal is associated with a significant 
decrease in mortality in patients with CAD, but a non-
significant increase in those with PAD [31]. 
The benefit for all patients achieving low levels of 
low-density lipoprotein cholesterol also supports the 
need for intensive lipid lowering in patients with PAD 
[5, 6, 32]. Aggressive therapy with statins in patients 
with PAD has significantly reduced all-cause mortality 
and the risk of stroke and shows a trend towards 
decreasing the risk of other cardiovascular end-points 
[33]. Statins have also been shown to improve survival 
for one year after vascular surgery [34, 35] and 
demonstrated a decreased incidence of embolic 
complications after endovascular aortic repair [34]. In 
addition, several studies in recent years have shown 
that statins improved pain-free walking distance, ankle-
brachial index values and treadmill exercise time [8, 
36]. Although Dosluoglu et al. [37] did not find a 
favorable statins effect on long-term stent or bypass 
patency and limb salvage, Sohn et al. [38] reported that 
compared with patients who did not use cholesterol-
lowering agents statin users were 35-43% less likely to 
experience lower extremity amputation. In this study, 
users of other cholesterol-lowering medications were 
not significantly different in terms of leg amputation 
risk [38]. Moreover, in another study, statin-treated 
patients with PAD after endovascular intervention had 
significantly higher rates of primary patency at 24 
months (43% vs 33%), secondary patency (66% vs 
51%), limb salvage (83% vs 62%), and overall survival 
(77% vs 62%) [39]. Identification of atherosclerosis 
risk factors in PAD patients may also help to identify 




1. Patients with PAD who qualified for 
endovascular therapy presented a greater 
prevalence of atherosclerosis risk factors and 
multisite vascular disease manifestation than 
various Polish populations investigated in large 
epidemiological studies, which demonstrated 
the poor achievement of target levels for 
controlling traditional atherosclerosis risk 
factors.  
2. Patients with PAD appeared to have a greater 
incidence of smoking, dyslipidemia, obesity 
and a history of prior myocardial infarction 
than the historical control group with ACS or 
ischemic stroke, which places them in the 
highest cardiovascular risk group.  
3. Our observations show the need for more 
careful management of patients with PAD as 
these individuals, of all those with vascular 
diseases, are the most likely to be at risk of a 
cardiovascular event and death. It also seems 
reasonable to start with education for patients’ 
family members in identifying and controlling 




1. Cantú-Brito C, Chiquete E, Ruiz-Sandoval JL, et al. 
Atherothrombotic disease, traditional risk factors, and 4-
year mortality in a Latin American population: the 
REACH Registry. Clin Cardiol. 2012;35(8):451-7. doi: 
10.1002/clc.22005. 
Adrianna Trofimiuk et al.  
 
64 
2. Fowkes FG, Rudan D, Rudan I, et al. Comparison of 
global estimates of prevalence and risk factors for 
peripheral artery disease in 2000 and 2010: a systematic 
review and analysis. Lancet. 2013;382(9901):1329-40. 
doi: 10.1016/S0140-6736(13)61249-0. 
3. Bartuś S, Siudak Z, Brzeziński M, et al. Percutaneous 
peripheral interventions in patients with multivessel 
coronary artery disease. Kardiol Pol. 2010;68(10):1115-
21. 
4. Norgren L, Hiatt WR, Dormandy JA, TASC II Working 
Group. Inter-Society Consensus for the Management of 
Peripheral Arterial Disease (TASC II). J Vasc Surg. 
2007;45 Suppl S:S5-67. 
5. European Stroke Organisation, Tendera M, Aboyans V, 
et al. ESC Guidelines on the diagnosis and treatment of 
peripheral artery diseases: Document covering 
atherosclerotic disease of extracranial carotid and 
vertebral, mesenteric, renal, upper and lower extremity 
arteries: the Task Force on the Diagnosis and Treatment 
of Peripheral Artery Diseases of the European Society of 
Cardiology (ESC). Eur Heart J. 2011;32(22):2851-906. 
doi: 10.1093/eurheartj/ehr211. 
6. Perk J, De Backer G, Gohlke H, et al. European 
Association for Cardiovascular Prevention & 
Rehabilitation (EACPR); ESC Committee for Practice 
Guidelines (CPG). European Guidelines on 
cardiovascular disease prevention in clinical practice 
(version 2012). The Fifth Joint Task Force of the 
European Society of Cardiology and Other Societies on 
Cardiovascular Disease Prevention in Clinical Practice 
(constituted by representatives of nine societies and by 
invited experts). Eur Heart J 2012;33:1635-701. doi: 
10.1093/eurheartj/ehs092. 
7. Jang SY, Ju EY, Cho SI, et al. Comparison of 
cardiovascular risk factors for peripheral artery disease 
and coronary artery disease in the Korean population. 
Korean Circ J. 2013;43(5):316-28. doi: 
10.4070/kcj.2013.43.5.316. 
8. Poredoš P, Jezovnik M, Kalodiki E, et al. Medical 
management of patients with peripheral arterial disease. 
Int Angiol. 2015;34(1):75-93. 
9. Ahn S, Park YJ, Min SI, et al. High prevalence of 
peripheral arterial disease in Korean patients with 
coronary or cerebrovascular disease. J Korean Med Sci. 
2012;27(6):625-9. 
10. Bez LG, Navarro TP. Study of carotid disease in patients 
with peripheral artery disease. Rev Col Bras Cir. 
2014;41(5):311-8. doi: 10.3346/jkms. 2012.27.6.625. 
11. Naderi N, Masoomi H, Mozaffar T, Malik S. Patient 
characteristics and comorbidities associated with 
cerebrovascular accident following acute myocardial 
infarction in the United States. Int J Cardiol. 
2014;175(2):323-7. doi: 10.1016/j.ijcard.2014.05.024.  
12. Kojima I, Ninomiya T, Hata J, et al. A low ankle brachial 
index is associated with an increased risk of 
cardiovascular disease: the Hisayama study. J 
Atheroscler Thromb. 2014;21(9):966-73. 
13. Gronewold J, Hermann DM, Lehmann N, et al. Ankle-
brachial index predicts stroke in the general population in 
addition to classical risk factors. Atherosclerosis. 
2014;233(2):545-50. doi: 10.1016/j.atherosclerosis. 
2014.01.044. 
14. Imori Y, Akasaka T, Ochiai T, et al. Co-existence of 
carotid artery disease, renal artery stenosis, and lower 
extremity peripheral arterial disease in patients with 
coronary artery disease. Am J Cardiol. 2014;113(1):30-5. 
doi: 10.1016/j.amjcard.2013.09.015. 
15. Aiman U, Haseen MA, Beg MH, et al. Profile of 
atherosclerotic risk factors and management in patients of 
peripheral arterial disease at a tertiary care teaching 
hospital of north India. Indian J Pharm Sci. 
2014;76(6):504-9.  
16. Cieśliński A, Pająk A, Podolec P, Rynkiewicz A (red.): 
Ogólnopolski Program Prewencji Choroby Wieńcowej 
POLSCREEN. 1st edition, Poznań, Termedia 
Wydawnictwo Medyczne; 2006, p: 32-38, 49, 59-64, 71,  
81-84. 
17. Gąsior M, Pres D, Gierlotka M, et al. The influence of 
diabetes on in-hospital and long-term mortality in 
patients with myocardial infarction complicated by 
cardiogenic shock: results from the PL-ACS registry. 
Kardiol Pol.2012;70(12):1215-24.  
18. Sielski J, Janion-Sadowska A, Sadowski M, et al. 
Differences in presentation, treatment, and prognosis in 
elderly patients with non‑ST‑ segment elevation 
myocardial infarction. Pol Arch Med Wewn. 
2012;122(6):253-61. 
19. Gierlotka M, Gąsior M, Tajstra M, et al. Outcomes of 
invasive treatment in very elderly Polish patients with 
non-ST-segment-elevation myocardial infarction from 
2003-2009 (from the PL-ACS registry). Cardiol J. 
2013;20(1):34-43. doi: 10.5603/CJ.2013.0007. 
20. Sanna T, Diener HC, Passman RS, et al. Cryptogenic 
stroke and underlying atrial fibrillation. N Engl J Med. 
2014;370(26):2478-86. doi: 10.1056/NEJMoa1313600. 
21. Agarwal AK, Singh M, Arya V, et al. Prevalence of 
peripheral arterial disease in type 2 diabetes mellitus and 
its correlation with coronary artery disease and its risk 
factors. J Assoc Physicians India. 2012;60:28-32. 
22. Endo M, Kumakura H, Kanai H, et al. Prevalence and 
risk factors for renal artery stenosis and chronic kidney 
disease in Japanese patients with peripheral arterial 
disease. Hypertens Res. 2010;33(9):911-5. doi: 
10.1038/hr.2010.93. 
23. Sumner AD, Khalil YK, Reed JF 3rd. The relationship of 
peripheral arterial disease and metabolic syndrome 
prevalence in asymptomatic US adults 40 years and 
older: results from the National Health and Nutrition 
Examination Survey (1999-2004). J Clin Hypertens 
(Greenwich). 2012;14(3):144-8. doi: 10.1111/j.1751-
7176.2011.00580.x.  
24. Yu JH, Hwang JY, Shin MS, et al. The prevalence of 
peripheral arterial disease in Korean patients with type 2 
diabetes mellitus attending a university hospital. Diabetes 
Metab J. 2011;35(5):543-50. doi: 10.4093/dmj. 
2011.35.5.543. 
25. Aboyans V, McClelland RL, Allison MA, et al. Lower 
extremity peripheral artery disease in the absence of 
Atherosclerosis risk factors in male patients qualified for percutaneous stenting of lower extremity arteries... 
 
65 
traditional risk factors. The Multi-Ethnic Study of 
Atherosclerosis. Atherosclerosis. 2011;214(1):169-73. 
doi: 10.1016/j.atherosclerosis. 2010.10.011.  
26. Satiroglu O, Kocaman SA, Karadag Z, et al. Relationship 
of the angiographic extent of peripheral arterial disease 
with coronary artery involvement. J Pak Med Assoc. 
2012;62(7):644-9. 
27. Radak D, Babic S, Peric M, et al. Distribution of risk 
factors in patients with premature coronary, supra-aortic 
branches and peripheral atherosclerotic disease. Med 
Princ Pract. 2012;21(3):228-33. doi: 10.1159/000334617.  
28. Agarwal S, Naderi S. Etiopathogenic differences in 
coronary artery disease and peripheral artery disease: 
results from the National Health and Nutrition 
Examination Survey. Angiology. 2014;65(10):883-90. 
doi: 10.1177/0003319713509303.  
29. Veenstra RP, ter Steege RW, Geelkerken RH, et al. The 
cardiovascular risk profile of atherosclerotic 
gastrointestinal ischemia is different from other vascular 
beds. Am J Med. 2012;125(4):394-8. doi: 
10.1016/j.amjmed.2011.09.013.  
30. Pająk A, Szafraniec K, Janion M, et al. The impact of the 
Polish national Programme of Cardiovascular Disease 
Prevention on the quality of primary cardiovascular 
disease prevention in clinical practice. Kardiol Pol. 
2010;68(12):1332-40. 
31. Alvarez LR, Balibrea JM, Suriñach JM, et al. Smoking 
cessation and outcome in stable outpatients with 
coronary, cerebrovascular, or peripheral artery disease. 
Eur J Prev Cardiol. 2013;20(3):486-95. doi: 
10.1177/1741826711426090.  
32. Hussein AA, Uno K, Wolski K, et al. Peripheral arterial 
disease and progression of coronary atherosclerosis. J 
Am Coll Cardiol. 2011;57(10):1220-5. doi: 
10.1016/j.jacc.2010.10.034. 
33. Antoniou GA, Fisher RK, Georgiadis GS, et al. Statin 
therapy in lower limb peripheral arterial disease: 
Systematic review and meta-analysis. Vascul Pharmacol. 





















34. Galiñanes EL, Reynolds S, Dombrovskiy VY, Vogel TR. 
The impact of preoperative statin therapy on open and 
endovascular abdominal aortic aneurysm repair 
outcomes. Vascular. 2014;Oct 14. pii: 
1708538114552837.  
35. Markel A. Statins and peripheral arterial disease. Int 
Angiol. 2014;   
36. Suckow BD, Kraiss LW, Schanzer A, et al. Statin therapy 
after infrainguinal bypass surgery for critical limb 
ischemia is associated with improved 5-year survival. J 
Vasc Surg. 2015;61(1):126-133.e1. doi: 
10.1016/j.jvs.2014.05.093. 
37. Dosluoglu HH, Davari-Farid S, Pourafkari L,  et al.. 
Statin use is associated with improved overall survival 
without affecting patency and limb salvage rates 
following open or endovascular revascularization. Vasc 
Med. 2014;19 (2):86-93. 
38. Sohn MW, Meadows JL, Oh EH, et al. Statin use and 
lower extremity amputation risk in nonelderly diabetic 
patients. J Vasc Surg. 2013;58(6):1578-1585.e1. doi: 
10.1016/j.jvs.2013.06.069. 
39. Aiello FA, Khan AA, Meltzer AJ, et al. Statin therapy is 
associated with superior clinical outcomes after 
endovascular treatment of critical limb ischemia. J Vasc 
Surg. 2012;55(2):371-9. doi: 10.1016/j.jvs.2011.08.044. 
 
 
Address for correspondence: 
Jacek Budzyński, MD, PhD 
Clinic of Vascular and Internal Diseases 
Jan Biziel University Hospital No. 2 in Bydgoszcz 
75 Ujejskiego Street 
85-168 Bydgoszcz 
Poland 




Accepted for publication: 10.06.2016 
 
